Sight Sciences (SGHT) News
NASDAQ: SGHTHealth CareMedical/Dental InstrumentsUSD
10.18-0.44 (-4.14%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SGHT news summary
We found 7 recent headlines mentioning Sight Sciences (SGHT): 1 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, SGHT is down 4.14% at $10.18. The most recent story, "What Drove Glaukos Stock's 48% Rally Since the End of September?", was published by Nasdaq on Nov 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Sight Sciences headlines
- What Drove Glaukos Stock's 48% Rally Since the End of September?Glaukos shares have surged 48.2% since September-end, fueled by strong Q3 results, raised sales guidance, Epioxa and iDose TR growth, and positive clinical data.NasdaqGKOS, ALC, ABBV, SGHT
- Sight Sciences Consensus Price Target Raised 10.14% to $11.07The average one-year price target for Sight Sciences (NASDAQGS:SGHT) has been revised to $11.07 / share. This is an increase of 10.14% from the prior estimate of $10.05 dated October 30, 2026. These…Nasdaq
- Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLidsNew direct practice expense supply code supports more consistent valuation of CPT 0563T New direct practice expense supply code supports more consistent valuation of CPT 0563TGlobeNewswire
- Sight Sciences signals $92M-$93M 2026 revenue outlook amid higher IDE target of ~$12MSeeking Alpha
- Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026MENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing…GlobeNewswire
- HC Wainwright & Co. Initiates Coverage of Sight Sciences with BuyFintel reports that on October 15, 2026, HC Wainwright & Co. initiated coverage of Sight Sciences (NASDAQGS:SGHT) with a Buy recommendation. On October 15, 2026, the latest close for the stock was…Nasdaq
- GKOS Stock Surges 67% Year to Date: What's Driving the Rally?Glaukos' iDose TR momentum and Epioxa launch are driving record growth, higher 2026 guidance and a broader ophthalmology platform.NasdaqGKOS, ALC, ABBV, SGHT